News
What's new in psilocybin
Trial results, FDA and DEA decisions, state laws, and the deals reshaping psychedelic medicine. We read the press releases so you don't have to.
Eli Lilly's $2.8B Psychedelic Bet: What It Means for Psilocybin
The maker of Prozac now owns a psychedelic pipeline. Here is why that matters.
Colorado's Psilocybin Program, One Year In
34 licensed healing centers, $3,500 programs, a new 2026 law, and how Colorado differs from Oregon.
Psilocybin's Road to FDA Approval: Where Compass Stands
Two Phase 3 wins, a priority voucher, and the four steps still between psilocybin and your doctor.
What the 2026 Psychedelics Executive Order Actually Does
$50 million for state programs, FDA priority vouchers, an ibogaine push, and what it means for psilocybin.
The FDA Just Wrote the Rulebook for Psychedelic Trials
Two monitors per session, new ways to handle blinding, and why therapy's role is still an open question.
New Mexico's Medical Psilocybin Program: Where It Stands
Producer permits are open, an equity fund is funded, and clinician permits are still coming.
Oregon's Legal Psilocybin Program Gets Its First Real Report Card
346 clients, 24 service centers, big drops in depression and anxiety, and the caveats that come with them.
Marijuana Got Rescheduled. Is Psilocybin Next?
Why the marijuana order skipped psilocybin, the two roads out of Schedule I, and the states getting ready.
HHS and the VA Team Up on Psychedelic Treatment for Veterans
A five-year federal agreement on psychedelic trials, training, and data for veterans, and what it means today.
Czechia Joins the Club: Where Medical Psilocybin Is Legal in 2026
Czechia's new law and the full map of countries where doctors can use psilocybin.